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Purpose: Patients reproduce symptoms of primary open-angle glaucoma (POAG) when treated with glucocorticoids
(GCs) topically on the eyes. Here we investigated the effects of GCs on junctional protein expression and cytoskeleton
organization in primary human trabecular meshwork (TM) cultures to understand the molecular pathologies of POAG.
Methods: Human TM cells from POAG (GTM) and age-matched nondiseased (NTM) individuals were obtained by
standard surgical trabeculectomy. Some of the cultures were treated with dexamethasone (DEX), a synthetic GC, at 1–
5×10−7 mol/l for 1–7 days. The expression levels of zonula occluden-1 (ZO-1) and connexin43 (Cx43) in TM cells with
or without DEX treatment were measured using reverse transcription (RT)–PCR, immunocytochemistry, and western blot
analysis.
Results: mRNA and proteins of ZO-1 and Cx43 were found in both NTM and GTM cells. ZO-1 and Cx43 were located
on the plasma membrane, especially along the border of adjacent cells. ZO-1 had no marked changes in localization in
NTM and GTM cells after treatment with 10−7 mol/l DEX for 48 h, whereas Cx43 appeared to increase in the cytoplasm.
mRNA of two ZO-1 isoforms, α+ and α–, were present in TM cells, and the former was expressed less than the latter.
Only ZO-1 α– isoform protein was expressed in NTM cells, whereas proteins of both isoforms were found in GTM cells.
DEX increased the protein levels of ZO-1 and Cx43 in both NTM and GTM cells. DEX also altered the F-actin architecture
and promoted cross-linked actin network formation, the effects of which were more pronounced in GTM cells.
Conclusions: Our findings not only provide molecular insights to the pathogenesis of GC-induced glaucoma but also
suggest that junctional proteins ZO-1 and Cx43 as well as F-actin are targets for developing new modalities in glaucoma
therapy.
Dexamethasone (DEX), a synthetic glucocorticoid (GC),
is a potent and effective ocular anti-inﬂammatory agent that
is topically applied in ocular conditions, such as keratitis,
uveitis,  and  iritis  [1].  However,  the  adverse  effects  of
prolonged  use  of  DEX  include  decreased  aqueous  humor
outflow and increased intraocular pressure (IOP), which may
cause the onset of secondary glaucoma. The exact molecular
mechanism of glucocorticoid-induced glaucoma (GIG) is still
elusive, but evidence points to excessive extracellular matrix
(ECM) material aggregation within the outﬂow channels in
trabecular  meshwork  (TM)  tissues  as  a  result  of  ECM
degradation inhibition, which subsequently leads to increased
outﬂow  resistance  [2-4].  GC-induced  ocular  hypertension
shares  some  clinical  features  with  primary  open-angle
glaucoma (POAG). Besides IOP elevation, both secondary
and primary glaucoma have selective retinal ganglion cell
death  that  causes  visual  field  changes,  nerve  fiber  layer
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defects,  and  eventual  irreversible  blindness  [4,5].  Several
studies have noted that the GC-induced changes in TM can
partially reflect the pathological mechanisms of POAG [6].
Investigations into the molecular mechanisms of GIG may
provide new insights into the pathology of POAG. Here we
use  DEX-treated  TM  cells  to  investigate  the  molecular
changes in TM cells obtained from nondiseased individuals
and POAG patients.
TM  regulates  the  drainage  rate  by  changing  the
intercellular space through a combination of actions. Other
than ECM turnover rate regulation, cellular contractility and
cellular  volume  are  partly  controlled  by  cytoskeleton  and
junctional  proteins.  F-actin,  a  major  component  of
cytoskeleton, is organized to respond to cell contraction and
to participate in generating forces responsible for continued
development and maintenance of tension [7]. Contraction of
the  TM  reduces  the  intercellular  spaces  and  thus  reduces
aqueous humor outflow [8]. A previous study showed that
DEX  induces  F-actin  expression  and  enhances  fibroblast-
mediated contraction [9]. In addition, actin becomes tangled
and  dysorganized  in  the  TM  and  Schlemm’s  canal  of
glaucomatous eyes or in DEX-treated cultures, in which these
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61cells  are  more  resistant  to  fluid  outflow  [10,11].  Actin
cytoskeleton  re-organization  also  alters  cell–ECM
interaction.
The presence of tight junctions and gap junctions has
been  demonstrated  in  TM  cells  using  freeze-fracture
techniques  [12-15].  Junctional-associated  proteins  zonula
occluden-1 (ZO-1) and connexin43 (Cx43) are thought to be
closely related to the fluid flow resistance [2,16]. F-actin
interacts  with  ZO-1  to  help  intercellular  tight  junction
assembly [17,18], in which the tightness and distribution of
the tight junctions influence the aqueous humor outflow rate
[13]. In addition, ZO-1 complexes with Cx43, a gap junction
protein [19], in which Cx43 is required for production of the
aqueous humor [20]. Since mutation of myocilin leads to the
early  onset  of  glaucoma,  we  speculate  that  mutation  of
ZO-1, a gene located on the same chromosome region as
myocilin (15q), may also lead to the pathology of glaucoma.
Molecular  alterations  of  TM  may  affect  the  outflow
facility and subsequently lead to pathogenesis of GIG and
POAG. In this study, we therefore focus on investigating how
glaucomatous conditions or DEX alters F-actin, ZO-1, and
Cx43  in  TM  cells.  We  observed  that  both  nondiseased
trabecular meshwork (NTM) cells and human TM cells from
individuals with POAG (GTM cells) express the ZO-1 α–
isoform,  while  the  α+  isoform  is  unique  to  GTM  cells,
indicating  the  possible  involvement  of  the  α+  isoform  in
transendothelial  outflow  resistance.  DEX  increases
expression of the tight junction-associated protein ZO-1 and
the gap junction protein Cx43 in both NTM and GTM cells.
DEX also aggravates actin cytoskeleton dysorganization and
cross-linked actin network (CLAN) formation in GTM cells.
METHODS
Chemical reagents: All tissue culture reagents were obtained
from Gibco BRL (Gaithersburg, MD). DEX was purchased
from Sigma (St. Louis, MO). Mouse anti-ZO-1, anti-Cx43,
and anti-vinculin were purchased from Zymed Laboratories
(San  Francisco,  CA).  Actin  cytoskeleton  and  the  Focal
Adhesion  Staining  kit  were  purchased  from  Chemicon
International, Inc. (Nutley, NJ).
Tissue  procurement  and  cell  culture:  We  followed  the
standard examination and tissue collection procedures [21,
22]. Prior to the surgery, clinical data were collected for each
patient, including age, gender, use of prostaglandin analogues,
number  of  argon  laser  trabeculoplasties  and  other  ocular
surgical interventions, type and duration of glaucoma, IOP,
and visual acuity. Glaucoma diagnosis was based on careful
clinical  eye  examination,  including  slit  lamp,  optical
coherence topography, gonioscopy, fundus photography, and
visual field. All patients underwent slit lamp examination
again the day before surgery.
Normal human eyes were obtained from the Zhongshan
Ophthalmic Center Eye Bank in Guangzhou, China [21,22].
The procurement of tissue was approved by the Institutional
Review Board Committee at the Sun Yat-sen University at
Guangzhou, China. Normal TM cells were collected from
eight post-mortem non-diseased human donor eyes within 24
h of death. The ages of the donors ranged from 20 to 60 years
and the gender was male. After written informed consent, TM
specimens from eight POAG patients (15–60 years, 8 males)
recruited in the Eye Hospital, Zhongshan Ophthalmic Center,
were  obtained  within  1  h  after  standard  surgical
trabeculectomy for therapeutic purposes. The TM tissues for
the POAG samples were obtained from individuals with a
similar  stage  of  glaucoma  after  diagnosis  by  glaucoma
specialists. These patients received the prostaglandin analogs,
latanoprost  (0.005%)  and  travoprost  (0.004%)  for  similar
lengths of time. None of the individuals from which the TM
samples  were  obtained  received  steroid  medications
previously. The average duration of glaucoma for the POAG
patients was approximately 2 years and none had a record of
systemic  disease.  Tissue  from  each  patient  was  used  to
generate primary cultures of TM cells, as described.
The TM tissue of each of the non-diseased donors and
POAG patients were used to generate an independent primary
culture of TM cells. The TM cells derived from the non-
diseased  donors  were  used  as  controls  in  the  following
experiments of this study. The samples were not pooled at any
time  in  these  experiments.  Primary  cultures  were  used  at
passage three to six for each experiment. Each study was
performed  three  times,  and  each  trial  contained  three
measurements of each sample. The average measurements
from these studies were used to generate the data.
Briefly, the human TM was carefully dissected from the
anterior segments and the whole corneal layer of the human
donor eyes. The explants were placed in 24-well culture plates
(Corning  Costar,  Cambridge,  MA)  containing  Dulbecco’s
modified  Eagle’s  medium,  which  was  supplemented  with
15% fetal bovine serum, 2 mmol/l L-glutamine, penicillin
(100 U/ml), and streptomycin (100 μg/ml). Cells from the TM
migrated  from  the  explants  in  approximately  7  days  and
formed a confluent monolayer 2–5 days later. Second- or
third-passage cells were used for all the studies described here.
Cells obtained from age-matched NTM cells and GTM cells
were seeded at a density of 1×105 cells/well, using 6-well
tissue  culture  plates  (Corning  Costar,  Cambridge,  MA).
Micrographs of the cultures were taken 3 days post seeding,
at approximately 80% confluency.
As described in our previous study [22], the expression
of  fibronectin  (FN),  laminin  (LN),  and  neuron-specific
enolase (NSE) was used to examine the primary TM cultures
established  from  normal  and  POAG  individuals  indeed
contain  TM  cells.  Briefly,  immunolabeling  studies  were
carried out on ice-cold 4% paraformaldehyde fixed TM cells.
After  permeabilization  using  Triton  X-100,  block  using
bovine  serum  albumin  (BSA),  and  quench  endogenous
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62peroxidase activity with 3% hydrogen peroxide (H2O2), the
cells were immunolabeled with mouse monoclonal anti-FN,
rabbit polyclonal anti-LN, or mouse monoclonal anti-NSE.
All  primary  antibodies  were  obtained  from  Santa  Cruz
Biotechnology (Santa Cruz, CA). After washes, the cells were
then incubated with biotinylated goat anti-mouse or goat anti-
rabbit IgG (Vector Laboratories), before reaction with the
avidin-biotin-peroxidase  complex.  We  also  incubated  the
cells with the secondary antibody alone as negative control.
After a series of washes, the specimens were treated with 3,3'-
diaminobenzidine (DAB)/peroxidase reaction (Vector DAB
substrate  kit;  Vector  Laboratories),  washed,  treated  with
hematoxylin counterstain, washed again, and then dried at
room temperature. The samples were then dehydrated in a
graded  series  of  alcohols  and  cover  slipped  with  1,  3-
diethyl-8-phenylxanthine  (DPX).  The  staining  pattern  for
each  antibody  was  visualized  using  a  phase-contrast
microscope (Leica, DM IRB, Germany).
Dexamethasone treatments: Stock solutions of 1 mM DEX
was dissolved in 95% ethanol and stored in 4 °C. NTM and
GTM cells were treated with DEX as mentioned below. All
TM cells were divided into control and treatment groups.
Treatment groups were grown in media containing 1×10−7
mol/l DEX to examine the change in expression of ZO-1 and
Cx43 and in 5×10−7 mol/l DEX to examine the organization
of the F-actin cytoskeleton. The control group was grown in
normal media and received equivalent volumes of ethanol.
Morphological  changes  in  the  primary  cultures  were
examined by light microscopy.
Analysis  of  ZO-1  and  Cx43  expression:  ZO-1  and  Cx43
mRNA expression were analyzed by reverse transcription
(RT)–PCR.  Total  RNA  from  NTM  and  GTM  cells  was
isolated using commercially available RNeasy kit (Qiagen,
Valencia, CA). Briefly, 2–10×106 cells/sample were lysed and
eluted through a mini spin column to enrich the RNA content.
After  partially  purified  RNA  was  treated  with  DNase  to
remove contaminating genomic DNA. First strand cDNA was
synthesized using the iScript cDNA synthesis kit (BioRad,
Hercules,  CA).  RT–PCR  was  performed  using  iTaq
polymerase (BioRad) at an annealing temperature of 55 °C for
35 cycles for ZO-1, Cx43, and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) primers. The PCR was harvested
during the linear part of the amplification increase. The primer
sequences for ZO-1 and Cx43 are (sense) 5′-GCA GCC ACA
ACC AAT TCA TAG-3′ and (antisense) 5′-GCA GAC GAT
GTT CAT AGT TTC G-3′; and (sense) 5′-CAA TCA CTT
GGC GTG ACT TC-3′ and (antisense) 5′-GTT TGG GCA
ACC TTG AGT TC-3′, respectively. The ZO-1 primers detect
both α+ (amplicon size=529 bp) and α– (amplicon size=290
bp) isoforms. GAPDH was used as the internal RNA loading
Figure 1. The morphology of trabecular
meshwork  cells  before  and  after
dexamethasone  treatment.  Normal
human  trabecular  meshwork  (NTM)
and  primary  open  angle  glaucoma
trabecular meshwork (GTM) cells were
obtained  and  cultured  under  identical
culture  protocol.  GTM  cells  were
slightly larger compared to NTM cells.
Cell morphology shows no significant
changes after treatment with 10−7 mol/l
DEX for 1 week (1W) compared to the
untreated control. Scale bar=50 μm.
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63control, and samples where no reverse transcriptase was added
to the PCR experiments were used as negative controls to
confirm  that  amplification  was  RNA  dependent.  PCR
products were resolved by 1.5% agarose gel electrophoresis.
For western blot analysis, NTM and GTM cells treated
with or without DEX were lysed using cytobuster lysis buffer
(Novagen, Madison, WI), and protein concentrations in the
supernatant were estimated using the Dc Protein Assay kit
(BioRad). Protein (30 μg) was separated by SDS–PAGE and
transferred onto nitrocellulose membranes (BioRad). After
blocking with 5% (w/v) nonfat dried milk, membranes were
incubated with primary antibodies (anti-ZO-1, 1:500 or anti-
Cx43, 1:1,000) overnight at 4 °C, followed by washes and
incubation  with  horseradish  peroxidase  (HRP)-conjugated
secondary antibodies for 1 h at room temperature. Bound
antibody  was  determined  using  the  Bio-Rad
electrochemiluminescence detection system.
F-actin  imaging  in  trabecular  meshwork  cells:  Phalloidin
binds specifically to the F-actin polymer in mammalian cells
and was used to visualize the organization of F-actin in TM
cells [23]. Cells seeded on polylysine (10 μg/ml)-coated glass
chamber  slides  at  a  density  of  2,000  cells/chamber  were
washed, fixed in ice-cold 4% paraformaldehyde for 15 min,
and permeabilized in 100 mM phosphate buffer containing
1 mg/ml bovine serum albumin, and 0.2% Triton X-100 for 4
min. After quenching the endogenous peroxidase activity with
3% H2O2, the cells were incubated with 0.5% blocking reagent
for 30 min (TSA-Direct kit; Dupont-NEN, Boston, MA). The
cells were then immunolabeled with anti-vinculin (1:200) at
room temperature for 1 h. Normal mouse immunoglobulin G
(IgG) was used instead of anti-vinculin in some experiments
to  serve  as  negative  controls.  After  incubation  with  the
primary antibody, the cells were washed and incubated for 45
min  with  fluorescein  isothiocyanate  (FITC)-antimouse
(1:200)  and  streptavidin-rhodamine  (TRITC)-conjugated
phalloidin (1:200; Chemicon International, Inc., Nutley, NJ)
for 1 h. After additional washes, the cells were mounted using
fluorescence mounting medium. (Vector Laboratories, Inc.,
Burlingame, CA) The staining pattern was visualized by a
Zeiss 100M confocal microscope (Carl Zeiss Jena GmbH,
Jena, Germany).
For qualitative evaluation of the actin cytoskeleton, a 40×
or 60× objective was used during confocal imaging, and a z-
series at 0.5- or 1.0-μm intervals was created. For each sample,
25 image fields were routinely photographed, and a total of
100 images were taken after four trials of the experiment. The
number of CLANs in each sample was counted using Aequitas
IDA  software  (version  1.3;  DDL  Ltd,  Cambridge,  UK).
CLANs were defined as a structure with at least five hubs and
three triangulated arrangements of spokes. The total number
of cells in each image were counted by using nuclei staining.
The severity of CLAN formation was presented as a ratio of
CLAN  number  to  cell  number.  Data  were  expressed  in
histogram form showing fold change to untreated NTM cells.
Statistical analysis: All assays were performed using at least
three  separate  experiments  in  triplicate,  and  data  were
expressed as mean±standard error (SE). A one-way analysis
of  variance  (ANOVA)  test  was  performed,  and  statistical
significance was set at p<0.05.
RESULTS
Dexamethasone  does  not  change  the  morphology  of
trabecular meshwork cells: As shown in Figure 1, both NTM
and GTM cells reached complete confluency at 7 days. GTM
cells  appeared  to  be  larger  and  more  irregular  in  shape
compared to NTM cells. TM cells incubated with DEX (10−7
M) for 7 days had no significant morphological changes, as
observed using phase-contrast light microscopy (Figure 1).
Trabecular meshwork cells express ZO-1 and Cx43: We next
examined the expression levels of ZO-1 and Cx43 in the TM
cells. Both NTM and GTM cells expressed ZO-1 isoforms and
Figure  2.  Trabecular  meshwork  cells
express zonula occludens 1 and Cx43.
NTM cells have lower zonula occludens
1 (ZO-1) α– isoform levels but higher
connexin 43 (Cx43) levels compared to
GTM cells, yet NTM and GTM cells
have  similar  ZO-1  α+  levels,  as
illustrated  by  RT–PCR.  GAPDH  was
used as the internal loading control. M
stands for molecular size ladder. n=3.
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64Cx43, as determined by RT–PCR (Figure 2). The ZO-1 α–
isoform was more abundantly expressed compared to the α+
isoform in both NTM and GTM cells (Figure 2). GTM cells
had higher levels of ZO-1 α– but lower Cx43 mRNA levels
compared to NTM cells (Figure 2). GAPDH was used as the
internal loading control.
Dexamethasone changes the expression of ZO-1 and Cx43 in
cultured  trabecular  meshwork  cells:  The
immunocytochemistry study showed the plasma membrane
localization  of  ZO-1  and  Cx43  in  NTM  cells  (Figure  3).
Exposure to 10−7 M DEX for 2 days had no change in the
expression level of ZO-1 and Cx43. However, DEX treatment
increased cytoplasmic Cx43 but had no effect on ZO-1. This
phenomenon may imply a problem assembling of the Cx43-
positive gap junction (Figure 3).
From western blot analysis, two ZO-1 isoforms were
identified by a slight molecular weight shift since the α+
isoform  is  80  amino  acids  longer  than  α–  isoform.  The
expression of the ZO-1 α– isoform and the Cx43 protein were
observed in both NTM and GTM cells, while the ZO-1 α+
isoform was unique to GTM cells (Figure 4). The levels of
ZO-1 and Cx43 increased with the number of days in culture
and peaked at around 4–5 days. This could be a result of
junction  formation  with  neighboring  cells  in  the  culture
(Figure 4). DEX induces an increase in the ZO-1 α+ isoform
specifically in GTM cells. Treatment with 10−7 M DEX caused
a time-dependent increase in both ZO-1 and Cx43 (Figure 4).
The peak expression of ZO-1 and Cx43 was observed at 4 days
and 5 days, and then the expression levels declined at 7days
but not to reach to the basal level (Figure 4). GAPDH was
used as the internal loading control.
Actin  dysorganization  in  trabecular  meshwork  cells  from
patients, aggravated by dexamethasone: Figure 5 shows the
distribution and organization of the F-actin cytoskeleton in
cultured TM cells with or without DEX treatment. Both GTM
and NTM cells are immunopositive to F-actin and vinculin
(Figure 5). Although CLANs were observed in both NTM and
GTM cells, the distribution of F-actin in GTM cells seems
more irregular and tangled compared to NTM cells (Figure 6).
DEX treatment increased overall actin staining in both NTM
and GTM cells. The expanded view showed CLAN formation
and serious actin tangling after DEX treatment (Figure 6). By
counting CLANs in micrographs obtained from three separate
experiments, DEX was found to cause 1.5-fold and 2.9-fold
more CLANs in NTM and GTM, respectively (Figure 7).
Figure 3. Effects of dexamethasone on zonula occludens 1 and connexin 43 in normal trabecular meshwork cells. Fixed normal trabecular
meshwork (NTM) cells were immunolabeled with zonula occludens 1 (ZO-1) and connexin 43 (Cx43) (green fluorescence) and observed
under a confocal microscope, using identical parameters. The ZO-1 antibody recognizes both α+ and α– isoforms of ZO-1. Both ZO-1 and
Cx43 were plasma membrane bound. Treatment with 10−7 mol/l dexamethasone (DEX) for 2 days resulted in no significant changes in
expression and distribution of ZO-1. However, DEX increased the cytoplasmic pool of Cx43. Nuclei are shown by DAPI staining (blue
fluorescence). The scale bar=20 μm.
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65DISCUSSION
GC-induced ocular hypertension and secondary open-angle
glaucoma  are  serious  adverse  effects  of  GC  therapy.  Its
clinical  presentation  is  similar  in  many  ways  to  POAG,
including increased aqueous humor outflow resistance and
morphological  and  biochemical  changes  to  the  TM.  IOP
elevation causes optic nerve damage and eventually leads to
blindness in late stages. Here we investigated the effects of
GCs on junctional protein and cytoskeleton organization in
normal or glaucomatous TM cells based on observations from
previous studies: (1) DEX treatment increases tight junction
protein ZO-1 expression in both TM and Schlemm’s canal
endothelial cells [2,24]; (2) ZO-1 has a direct interaction with
Cx43, through which intercellular communication and barrier
functions  are  mediated  [25,26];  and  (3)  ZO-1  affects  cell
contractility  via  binding  to  cytoskeleton  actin  through
anchoring protein α-actinin [27,28].
ZO-1 has two splice variants, α+ and α–. The α+ isoform,
which is the longer isoform, contains an additional 80 amino
acids, is usually found in structurally less dynamic junctions,
and is mostly detected in epithelial cells. In contrast, the α–
isoform  expresses  in  more  dynamic  junctions  and  is
commonly  found  in  endothelial  cells  [29,30].  During
embryonic development, the α+ isoform appears right before
formation  of  the  nascent  blastocele  and  tight  junctions,
whereas  the  α–  isoform  is  present  much  earlier  at  the
blastomere stage before tight junctions are assembled [31]. In
agreement with the findings of Alvarado and colleagues that
TM cells have less α+ protein relative to α– protein [24], we
found an almost twofold less abundance of α+ mRNA levels
compared  to  α–  (Figure  3),  indicating  junctions  of  lower
resistance  may  be  found  in  NTM  cells  that  allow  more
dynamic activities between cells. Interestingly, the α+ protein
is too weak to be detected in NTM cells regardless of the
treatment, but treatment with DEX induces a strong α+ signal
in GTM cells, while the α– signal fades out in GTM cells
(Figure 4). Studies on ZO-1 distribution suggest that the α+
isoform forms high-resistance junctions, while the α– isoform
is present in relatively leaky adherens-type junctions [31].
This  may  explain  the  high  aqueous  outflow  resistance  in
glaucomatous TM samples. In addition, since the α+ isoform
forms a less active junction, the strong expression of α+ in
GTM cells may indicate a loss of function change in the TM
structure.
On  the  other  hand,  Cx43  is  the  most  ubiquitously
expressed vertebrate gap junction protein that is located on
lateral plasma membrane to facilitate cell-cell communication
[28,30]. The gap junctions allow both intercellular ionic and
biochemical coupling to facilitate movement of ions (e.g.,
potassium) and small molecules (e.g., metabolites, sugars,
lactate,  and  butyrate)  as  well  as  intracellular  signaling
molecules (e.g., cyclic nucleotides) [30,32]. Cx43 is found in
both NTM and GTM cells. DEX increases the cytoplasmic
pool  of  Cx43,  indicating  that  the  Cx43  protein  fails  to
incorporate into gap junctions. The cellular aggregation of
Cx43 may create a crowd effect and interfere with normal
cellular functioning.
Apart from the junctional status, the cytoskeleton also
controls the drainage rate of the TM. The distribution and
organization of F-actin affects the contractility of the TM, in
which contraction decreases and relaxation increases aqueous
drainage [33,34]. Since the cytoskeleton also plays a role in
maintaining  cell  polarity  and  orienting  the  metabolic  and
signal transduction machinery in cells, dysorganization of the
cytoskeleton can greatly distort the functionality and integrity
of TM cells [33-36]. In line with other observations, there are
more CLANs in GTM and in cells exposed to DEX (Figure
6)  [11,37].  CLANs  are  polygonal  structures,  and  little  is
known  about  their  functional  significance  and  formation
mechanisms. Atomic force measurements indicate that they
Figure  4.  Dexamethasone  increases
zonula  occludens  1  and  connexin  43
expression  in  trabecular  meshwork
cells. Western blot analysis showed the
expression  of  zonula  occludens  1
(ZO-1) and connexin 43 (Cx43) protein
in  trabecular  meshwork  (TM)  cells.
NTM cells express the ZO-1 α– isoform
and Cx43 protein, whereas GTM cells
express both ZO-1 isoforms and Cx43
protein.  Treatment  with  10−7  mol/l
dexamethasone  (Dex)  caused  a  time-
dependent increase in both ZO-1 and
Cx43, with peak expression at 4 and 5
days, followed by a gentle decline at 6
days;  however,  the  levels  of  these
proteins were not at the basal level after
7 days. GAPDH was used as the internal
loading control and n=3.
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66Figure 5. The cytoskeleton architecture of glaucomatous trabecular meshwork cells is tangled. The organization of the filamentous actin (F-
actin; red fluorescence), and the distribution of vinculin (green fluorescence), the actin focal adhesion point on plasma membrane, were
observed using confocal microscopy. The glaucomatous trabecular meshwork cells have a more irregular actin architecture and vinculin
distribution compared to normal trabucular meshwork cells.
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67Figure 6. Treatment with 10−7 mol/l dexamethasone (DEX) for 7 days increased cross-linked actin networks formation in both normal trabecular
meshwork and trabecular meshwork cells derived from POAG individuals cells. cross-linked actin networks (CLANs) were also observed in
the untreated trabecular meshwork cells derived from POAG individuals (GTM) cells. Green squares indicate areas of enlargement. Nuclei
were shown by DAPI staining (blue fluorescence).
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68seem to impart rigidity to the cell because the geodesic cross-
linking  arrangements  are  believed  to  make  the  TM  cells
“stiffer”  and  therefore  more  resistant  to  aqueous  outflow
[38,39]. Although we do not know whether CLANs are the
initiator or the result of glaucoma, the current observations
prompt us to hypothesize that suppression of CLAN formation
or reversal of CLANs may be of therapeutic importance for
POAG.
For example, latrunculin-A and -B, isolated from marine
sponge, are a potent microfilament disruptor by sequestering
actin.  These  compounds  can  prevent  and  reverse  DEX-
induced  actin  cytoskeleton  re-organization  as  well  as
effectively  increase  the  outflow  facility  when  topically
applied  on  nonhuman  primate  eyes  [40]  and  postmortem
human  eyes  [41].  Since  latrunculin-A  and  other  actin
depolymerizing agents, such as cytohalasin D, can enhance
matrix metalloprotease-2 activities to degrade and remodel
ECM, and activate other cell survival molecules, including
p38  mitogen-activated  protein  kinases  (MAPK)  and
extracellular signal-regulated kinases (ERK1/2), in TM cells
[42]. Thus, these agents are now under intensive investigation
for development of future glaucoma therapy.
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